| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
73,340,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
924,021 |
Avg
Vol: |
417,434 |
| 52
Week Range: |
$124.7 - $124.7 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Freeman Scott M |
VP, Clinical Research |
• – – |
2004-04-08 |
4 |
S |
$43.57 |
$217,908 |
D/D |
(5,000) |
4,114 |
|
- |
|
| Freeman Scott M |
VP, Clinical Research |
• – – |
2004-04-08 |
4 |
OE |
$4.00 |
$20,000 |
D/D |
5,000 |
9,114 |
|
- |
|
| Renton Hollings |
President and CEO |
• • – |
2004-04-05 |
4 |
S |
$43.77 |
$109,537 |
I/I |
(2,500) |
92,785 |
|
- |
|
| Renton Hollings |
President and CEO |
• • – |
2004-03-29 |
4 |
S |
$41.04 |
$102,758 |
I/I |
(2,500) |
95,285 |
|
- |
|
| Jew Jeanne Y |
VP, Corporate & Commercial Dev |
• – – |
2004-03-29 |
4 |
S |
$39.96 |
$87,912 |
D/D |
(2,200) |
0 |
|
- |
|
| Jew Jeanne Y |
VP, Corporate & Commercial Dev |
• – – |
2004-03-29 |
4 |
OE |
$5.00 |
$12,752 |
D/D |
2,200 |
2,200 |
|
- |
|
| Post Leonard E |
SVP, Research & Development |
• – – |
2004-03-26 |
4 |
S |
$39.40 |
$395,059 |
D/D |
(10,000) |
14,729 |
|
- |
|
| Post Leonard E |
SVP, Research & Development |
• – – |
2004-03-26 |
4 |
OE |
$10.00 |
$100,000 |
D/D |
10,000 |
24,729 |
|
- |
|
| Wortzman Marilyn E |
VP, Finance and Administration |
• – – |
2004-03-25 |
4 |
S |
$37.50 |
$99,113 |
D/D |
(2,643) |
486 |
|
- |
|
| Wortzman Marilyn E |
VP, Finance and Administration |
• – – |
2004-03-25 |
4 |
OE |
$4.00 |
$11,965 |
D/D |
2,643 |
3,129 |
|
- |
|
| Wierenga Wendall D |
Director |
– • – |
2004-03-23 |
4 |
S |
$36.47 |
$109,599 |
D/D |
(3,000) |
0 |
|
- |
|
| Wierenga Wendall D |
Director |
– • – |
2004-03-23 |
4 |
OE |
$7.75 |
$23,250 |
D/D |
3,000 |
3,000 |
|
- |
|
| Post Leonard E |
SVP, Research & Development |
• – – |
2004-03-22 |
4 |
S |
$36.00 |
$360,208 |
D/D |
(10,000) |
14,729 |
|
- |
|
| Post Leonard E |
SVP, Research & Development |
• – – |
2004-03-22 |
4 |
OE |
$10.00 |
$100,000 |
D/D |
10,000 |
24,729 |
|
- |
|
| Giotta Gregory J |
VP & Chief Legal Counsel |
• – – |
2004-03-22 |
4 |
S |
$36.00 |
$173,293 |
D/D |
(4,813) |
0 |
|
- |
|
| Giotta Gregory J |
VP & Chief Legal Counsel |
• – – |
2004-03-22 |
4 |
OE |
$4.00 |
$21,190 |
D/D |
4,813 |
4,813 |
|
- |
|
| Renton Hollings |
President and CEO |
• • – |
2004-03-22 |
4 |
S |
$35.69 |
$89,247 |
I/I |
(2,500) |
97,785 |
|
- |
|
| Renton Hollings |
President and CEO |
• • – |
2004-03-15 |
4 |
S |
$35.84 |
$89,874 |
I/I |
(2,500) |
100,285 |
|
- |
|
| Renton Hollings |
President and CEO |
• • – |
2004-03-08 |
4 |
S |
$37.53 |
$94,001 |
I/I |
(2,500) |
102,785 |
|
- |
|
| Freeman Scott M |
VP, Clinical ResearchOfficer |
• – – |
2004-03-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,995 |
|
- |
|
| Wood Julianna R |
VP, Corp. Communication/I.R.Of |
• – – |
2004-03-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
200 |
|
- |
|
| Renton Hollings |
President and CEO |
• • – |
2004-03-01 |
4 |
S |
$36.47 |
$91,359 |
I/I |
(2,500) |
99,889 |
|
- |
|
| Renton Hollings |
President and CEO |
• • – |
2004-02-23 |
4 |
S |
$34.68 |
$86,711 |
I/I |
(2,500) |
102,389 |
|
- |
|
| Renton Hollings |
President and CEO |
• • – |
2004-02-17 |
4 |
S |
$33.78 |
$84,694 |
I/I |
(2,500) |
104,889 |
|
- |
|
| Renton Hollings |
President and CEO |
• • – |
2004-02-09 |
4 |
S |
$33.53 |
$83,938 |
I/I |
(2,500) |
107,389 |
|
- |
|
688 Records found
|
|
Page 26 of 28 |
|
|
